128 related articles for article (PubMed ID: 29187404)
1. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
[TBL] [Abstract][Full Text] [Related]
2. Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes.
Lai D; Wang F; Chen Y; Wang C; Liu S; Lu B; Ge X; Guo L
Cancer Immunol Immunother; 2012 Jul; 61(7):979-89. PubMed ID: 22120758
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Funauchi M; Serada S; Hiramatsu K; Funajima E; Kanda M; Nagase Y; Nakagawa S; Ohkawara T; Fujimoto M; Suzuki Y; Ueda Y; Kimura T; Naka T
Int J Cancer; 2024 Feb; 154(3):425-433. PubMed ID: 37728485
[TBL] [Abstract][Full Text] [Related]
4. SSRI use and clinical outcomes in epithelial ovarian cancer.
Christensen DK; Armaiz-Pena GN; Ramirez E; Matsuo K; Zimmerman B; Zand B; Shinn E; Goodheart MJ; Bender D; Thaker PH; Ahmed A; Penedo FJ; DeGeest K; Mendez L; Domann F; Sood AK; Lutgendorf SK
Oncotarget; 2016 May; 7(22):33179-91. PubMed ID: 27121207
[TBL] [Abstract][Full Text] [Related]
5. Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.
Cai Q; Zhao Z; Antalis C; Yan L; Del Priore G; Hamed AH; Stehman FB; Schilder JM; Xu Y
FASEB J; 2012 Aug; 26(8):3306-20. PubMed ID: 22767227
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1.
Nakae A; Kodama M; Okamoto T; Tokunaga M; Shimura H; Hashimoto K; Sawada K; Kodama T; Copeland NG; Jenkins NA; Kimura T
Biochem Biophys Res Commun; 2021 May; 552():120-127. PubMed ID: 33744759
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.
Kobayashi R; Deavers M; Patenia R; Rice-Stitt T; Halbe J; Gallardo S; Freedman RS
Cancer Immunol Immunother; 2009 Feb; 58(2):247-58. PubMed ID: 18618111
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.
Uno K; Koya Y; Yoshihara M; Iyoshi S; Kitami K; Sugiyama M; Miyamoto E; Mogi K; Fujimoto H; Yamakita Y; Wang X; Nawa A; Kajiyama H
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338902
[TBL] [Abstract][Full Text] [Related]
9. Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.
Takheaw N; Sittithumcharee G; Kariya R; Kasinrerk W; Okada S
Cancer Immunol Immunother; 2021 Jun; 70(6):1557-1567. PubMed ID: 33215253
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer.
Liu CL; Yuan RH; Mao TL
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356623
[TBL] [Abstract][Full Text] [Related]
11. Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.
Zeng Z; Lin C; Zhang MC; Kossinna P; Wang P; Cao D; Wang J; Xu M; Wang X; Li Q; Xu X; Yang H; Zhu S; Liu GR; Xie K; Yang J; Luo Y; Wang Y; Zhang XH; Lin J; Chen H; Liu SL; Liu H
Phytother Res; 2023 Oct; 37(10):4722-4739. PubMed ID: 37443453
[TBL] [Abstract][Full Text] [Related]
12. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype.
Alvero AB; Montagna MK; Craveiro V; Liu L; Mor G
Am J Reprod Immunol; 2012 Mar; 67(3):256-65. PubMed ID: 21917055
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.
Russell S; Duquette M; Liu J; Drapkin R; Lawler J; Petrik J
FASEB J; 2015 Feb; 29(2):576-88. PubMed ID: 25395453
[TBL] [Abstract][Full Text] [Related]
14. Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy.
Sakamoto S; Inoue H; Kaneko MK; Ogasawara S; Kajikawa M; Urano S; Ohba SI; Kato Y; Kawada M
Cancer Sci; 2019 Nov; 110(11):3595-3602. PubMed ID: 31512325
[TBL] [Abstract][Full Text] [Related]
15. An RGDKGE-Containing Cryptic Collagen Fragment Regulates Phosphorylation of Large Tumor Suppressor Kinase-1 and Controls Ovarian Tumor Growth by a Yes-Associated Protein-Dependent Mechanism.
Han X; Caron JM; Lary CW; Sathyanarayana P; Vary C; Brooks PC
Am J Pathol; 2021 Mar; 191(3):527-544. PubMed ID: 33307038
[TBL] [Abstract][Full Text] [Related]
16. MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism.
Wang L; Zhu H; Shi Z; Chen B; Huang H; Lin G; Li J; Yu H; Xu S; Chen G; Ou R; Dai C
Theranostics; 2024; 14(1):75-95. PubMed ID: 38164137
[No Abstract] [Full Text] [Related]
17. Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies.
Stasenko M; Smith E; Yeku O; Park KJ; Laster I; Lee K; Walderich S; Spriggs E; Rueda B; Weigelt B; Zamarin D; Rao TD; Spriggs DR
Sci Rep; 2021 Feb; 11(1):3718. PubMed ID: 33580170
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort.
Ose J; Fortner RT; Schock H; Peeters PH; Onland-Moret NC; Bueno-de-Mesquita HB; Weiderpass E; Gram IT; Overvad K; Tjonneland A; Dossus L; Fournier A; Baglietto L; Trichopoulou A; Benetou V; Trichopoulos D; Boeing H; Masala G; Krogh V; Matiello A; Tumino R; Popovic M; Obón-Santacana M; Larrañaga N; Ardanaz E; Sánchez MJ; Menéndez V; Chirlaque MD; Travis RC; Khaw KT; Brändstedt J; Idahl A; Lundin E; Rinaldi S; Kuhn E; Romieu I; Gunter MJ; Merritt MA; Riboli E; Kaaks R
Br J Cancer; 2015 Jan; 112(1):162-6. PubMed ID: 25349976
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells
Bai M; Cui M; Li M; Yao X; Wu Y; Zheng L; Sun L; Song Q; Wang S; Liu L; Yu C; Huang Y
Int J Biol Sci; 2021; 17(13):3493-3507. PubMed ID: 34512161
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis.
Frederick MI; Hovey OFJ; Kakadia JH; Shepherd TG; Li SSC; Heinemann IU
Mol Cell Proteomics; 2023 Nov; 22(11):100660. PubMed ID: 37820923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
